KYMR
Kymera Therapeutics Inc.
$51.01
+$1.88(+3.83%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$3.51B
Volume
730.91K
52W Range
$19.45 - $53.27
Target Price
$63.05
Key Metrics Overview
| Market Cap | $3.51B | P/E Ratio | N/A |
| 52W High | $53.27 | 52W Low | $19.45 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -12.6% | 52W Position | 93.3% |
| Overall Score | 40 | Value Score | -- |
| Quality Score | -- | Technical Score | 40 |
Growth Analysis
| EPS Current Est | $-3.29 | EPS Next Est | $-3.89 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYMR | $51.01 | +3.8% | 730.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kymera Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW